GEM

Government Tender Published for TAB ANASTROZOLE 1 MG,TAB AZATHIOPRINE 100MG,TAB BICALUTAMIDE 50 MG,TAB EVEROLIMUS 0 point 5 MG,CAP in HYDERABAD, TELANGANA

Posted

22 Mar 2025, 08:52 am

Deadline

12 Apr 2025, 09:00 am

Progress

RA
Issue22 Mar 2025, 08:52 am
Reverse Auction25 Apr 2025, 07:00 pm
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

47560

Categories 3

A tender has been published for Indian Army TAB ANASTROZOLE 1 MG, TAB AZATHIOPRINE 100MG, TAB BICALUTAMIDE 50 MG, TAB EVEROLIMUS 0 point 5 MG, CAP NIFEDIPINE RETARD 20 MG, TAB TACROLIMUS 1 MG, TAB TAMOXIFEN CITRATE 20 MG, TAB TADALAFIL 20 MG, TAB ACENOCOUMAROL 1 MG, TAB DILTIAZEM 90 MG Controlled Delivery, TAB ACENOCOUMAROL 2MG, TAB INDAPAMIDE SR 1point 5 MG, TAB ISOSORBIDE DINITRATE 10 MG, TAB ISOSORBIDE 5 MONONITRATE 20 MG, TAB PERINDOPRIL 4 MG in HYDERABAD, TELANGANA. Quantity: 47560 by. Submission Deadline: 12-04-2025 09: 00: 00. Check eligibility and apply.

Bill of Quantities (BOQ) 15 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 TAB ANASTROZOLE 1 MG TAB 1,000 no ms18473f 30
2 TAB AZATHIOPRINE 100MG TAB 300 no ms18473f 30
3 TAB BICALUTAMIDE 50 MG TAB 2,700 no ms18473f 30
4 TAB EVEROLIMUS 0 point 5 MG TAB 360 no ms18473f 30
5 CAP NIFEDIPINE RETARD 20 MG TAB 6,500 no ms18473f 30
6 TAB TACROLIMUS 1 MG TAB 600 no ms18473f 30
7 TAB TAMOXIFEN CITRATE 20 MG TAB 600 no ms18473f 30
8 TAB TADALAFIL 20 MG TAB 300 no ms18473f 30
9 TAB ACENOCOUMAROL 1 MG TAB 3,800 no ms18473f 30
10 TAB DILTIAZEM 90 MG Controlled Delivery TAB 7,800 no ms18473f 30
11 TAB ACENOCOUMAROL 2MG TAB 2,400 no ms18473f 30
12 TAB INDAPAMIDE SR 1point 5 MG TAB 5,700 no ms18473f 30
13 TAB ISOSORBIDE DINITRATE 10 MG TAB 5,600 no ms18473f 30
14 TAB ISOSORBIDE 5 MONONITRATE 20 MG TAB 7,800 no ms18473f 30
15 TAB PERINDOPRIL 4 MG TAB 2,100 no ms18473f 30

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Reverse Auction Schedule

Completed

Start

25 Apr 2025, 07:00 pm

End

26 Apr 2025, 07:00 pm

Duration: 24 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Frequently Asked Questions

What are the eligibility requirements for **GEM/2025/B/6078870**?

The eligibility requirements include being a registered entity with necessary licenses to supply pharmaceuticals. Additionally, bidders should demonstrate prior experience in supplying similar products, especially to government or military organizations. Compliance with these conditions is critical to participate successfully in the tender.

What specific technical specifications must be adhered to in this tender?

Bidders need to adhere to strict technical specifications that demand compliance with national quality standards. Suppliers must ensure that all pharmaceuticals are produced in ISO certified facilities and that they can provide comprehensive evidence of quality assurance and testing processes that align with military health regulations.

What are the **payment terms** associated with this tender?

The payment terms for this tender will be outlined in the final contract agreement. Typically, payment may be processed upon delivery and successful inspection of the pharmaceuticals. Bidders should be prepared to adhere to government payment protocols outlined at the point of contract negotiation.

How are the submitted documents evaluated during the selection process?

The evaluation process is conducted in two phases: a technical evaluation which assesses compliance against the tender's requirements and a financial evaluation that examines pricing proposals and financial viability. Bidders are ranked based on a combined score from both evaluations, leading to the selection of the most suitable candidate.

What opportunities exist for **Micro, Small, and Medium Enterprises (MSEs)** within this tender?

This tender comes with special provisions to encourage participation from Micro, Small, and Medium Enterprises (MSEs), which can receive support and potentially favorable evaluation during the decision-making process. Embracing MSEs is part of a broader initiative to foster inclusivity in government procurement, thereby enabling diverse suppliers to contribute to military supply chains.